Agreement worth up to $1.2bn includes plan for combined flu and Covid shots
Latest data from UK Health Security Agency shows jump in cases in first three months of the year
The technology can do wonderful things — but its achievements should not come at the expense of basic protections
AlphaFold 3 aims to reveal biological secrets and boost drug search efforts
Anglo-Swedish drugmaker says availability of newer vaccines hit demand for jab
Food and Drug Administration poised to call for outside assessment of Lykos PTSD therapy in test for psychedelics sector
Weight-loss treatments are not the only source of excitement in the pharmaceutical research world
Novo Nordisk, Bill & Melinda Gates Foundation and Wellcome focus on interlinked issues
Experts warn better data is required to drive policy as debilitating condition reduces workforce
While pandemic risk is low, scientists say urgent investigations into the virus are necessary
For stretched public health budgets, high-tech treatments are hard to afford but some pre-emptive measures can prove good value
Wellcome’s John-Arne Røttingen says divisions risk harming action on pandemic responses and ‘superbugs’
Now is not a time for paranoia but there is a case for extreme vigilance
Global warming, flooding and pollution could all help promote evolution of pathogens
Habitat encroachment means more opportunities for animal-to-human infection
Changing climate and human population shifts have spread and strengthened foothold
The FT’s fifth annual ranking of the region’s businesses by revenue growth. Plus: outsourcers tap into remote work boom; Shopify targets more growth from bigger clients; Brazil’s alternative to electric vehicles; and Vertex Pharmaceutical’s potential answer to the opioid crisis
Technique devised for Timothy syndrome could open way to therapies for other untreatable conditions
Technique highlights concerns shifting global disease burden as populations age
High costs and concerns over efficacy and side effects limit uptake of first treatment as another nears approval
Research harnesses power of generative artificial intelligence in latest sign of its potential use in medicine
Study results could encourage US Medicare system and private insurers to cover tirzepatide treatments
UK research highlights risk of over-diagnosis and gaps in spotting serious variants of the disease
The idea that the technology might accelerate general human capabilities remains fanciful
Growing number of countries are also considering whether to amend legislation
International Edition